This study investigates the effects of an investigational medication when used alone and with another treatment for pancreatic cancer.
The purpose of this study is to evaluate the safety and effectiveness of the investigational medication for people with pancreatic cancer. It checks for any side effects and how well the treatment works.
- Who can participate: Adults over 18 years with pancreatic ductal adenocarcinoma or undifferentiated carcinoma of the pancreas can participate. They must have good overall health and be able to perform daily activities. Those with certain medical conditions or previous treatments may not be eligible.
- Study details: Participants will receive the investigational medication alone or with gemcitabine. The study will evaluate the safety and effects of these treatments.
How understandable was the trial content above?
Hard to understand
Easy to understand